According to Future Market Insights (FMI), the intestinal fistula treatment market is projected to grow at a 5.3% CAGR from 2026 to 2036. Anticholinergics are expected to lead the drug class segment with a 26.3% share, while hospital pharmacies account for 57.2% of distribution. The market is expanding as post-surgical intestinal complications and inflammatory bowel disease increase demand for...